Jiabing Zhou
No ORCID on file
· 1 paper in corpus
BACKGROUND: RNA interference technology has shown high therapeutic potential for cancer treatment. However, serum instability, poor tissue permeability and non-specific uptake of short interfering RNA (siRNA) limit its administration in viv…